Inflammation as a causative factor in the aetiology of Parkinson's disease
about
Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesNon-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesAssociation between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-AnalysisOxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's diseaseA Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced deathGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesParainflammation, chronic inflammation, and age-related macular degenerationCellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseParkinson's disease, insulin resistance and novel agents of neuroprotectionPotential mechanisms of progranulin-deficient FTLDUncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repairNeural stem cell niches in health and diseasesA review of experimental evidence linking neurotoxic organophosphorus compounds and inflammationMetabolic syndrome: an important risk factor for Parkinson's diseaseExtracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammationThe central role of hypothalamic inflammation in the acute illness response and cachexiaNeuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oilAdult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cellsParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisInhalation of environmental stressors & chronic inflammation: autoimmunity and neurodegenerationEffects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cellsLoss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stressMitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifyingA Novel Microfluidic Cell Co-culture Platform for the Study of the Molecular Mechanisms of Parkinson's Disease and Other SynucleinopathiesNitrated alpha-synuclein and microglial neuroregulatory activities.Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.Association of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective studyNeuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic interventionLRRK2 levels in immune cells are increased in Parkinson's diseaseTargeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.Selective neuronal vulnerability to oxidative stress in the brain.Evidence of inflammatory system involvement in Parkinson's disease.Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's diseaseLipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.Intravitreous delivery of the corticosteroid fluocinolone acetonide attenuates retinal degeneration in S334ter-4 rats.Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.Estrogen-related and other disease diagnoses preceding Parkinson's disease
P2860
Q24235107-D30A7154-1EEB-4229-9176-3A4086959234Q24236199-6F643DAD-E52F-4DE3-97FB-665CACD460ECQ24282619-0EC02713-3964-4420-9908-324F012BCB69Q24337079-4376AD70-592F-470F-AA03-5F491350F2D5Q24644712-10966574-7070-4BBA-9455-412BDC46CC2EQ26767289-A1E547C9-E5B6-4F41-87EE-BB65E420E2B8Q26779933-A79CD3AC-EC3B-4731-9316-751DE7052328Q26796268-AB9BE94A-A302-41B9-9D24-429A03C4B02AQ26849232-F5009EE5-FD50-4BCA-BB9A-79C6DC3CA7E6Q26853311-C4CCBF0F-4529-455D-B458-3342CC652475Q26863702-CE2C21FB-C39C-4CF9-BB37-D11990F41094Q26865502-811C154D-D7B8-4111-8566-FF8526AE95ECQ26995185-0E853C2B-E4BD-4C2A-8A57-12C00E4EBB93Q27022179-6E5C363D-C726-4870-A35D-36EAB0D3114FQ27023711-470DAB48-4F37-4253-9A4B-2D29AAB209E7Q27314800-66C82B76-DE80-422D-B0AB-A95FDD70D9CFQ28080648-CB338DA6-5342-44BD-903D-621479A53C1CQ28236740-3601B44F-84ED-47BD-AD2F-ECCD9D4CCF65Q28284530-CB92B8A4-BCE1-41DB-950E-002661739660Q28384572-355CF6C8-7761-4D7E-A0DE-2AB200D6962BQ28388503-0FF8D850-6030-45AA-8C9B-B7F5DBE6D942Q28571669-691FDD4D-7965-471F-9D1E-20CC10BFF832Q28592727-88259E57-97CE-43D4-821E-EF8457D4F24DQ28732683-9E11654D-AFE6-40E2-898F-ECFCE70478C5Q30828564-575FD022-0790-402E-A346-D3F004755CFCQ33315262-706E1EBE-7BE8-4BE0-B3DF-F955F1298A9FQ33353554-DE903C46-FA7C-4C25-A98D-312BD0FEAAF5Q33389138-ECBDF665-69D5-4787-86CB-56CA592956C9Q33637422-7875E602-9B4B-4A1B-90CD-6C4074C249DCQ33663970-D980E558-3402-4E0E-9437-11657CA0CA80Q33765746-0A354270-5540-4664-9BBB-310176C8EBC9Q33771694-F1A5627F-B69F-4DD2-A4C5-56FB268EBB1CQ33778472-D419F40F-9C54-4EAC-98E9-ADF57E5FD460Q33868370-399F2821-E492-4AAB-85E3-64818F2EE8BCQ33890818-ADD4AB7B-1859-4385-AD91-482CA92CBC86Q33892744-3440A934-EAB0-449F-A475-72B87BD452A2Q33999914-CD3E4FAF-445E-4C89-8C62-52ABAFE4B340Q34022619-69E434D9-87C7-4AC2-8BC3-ABCD628D4284Q34092416-96611197-39D7-4A83-995C-1AE13F6B2B62Q34144121-7B448B72-07BA-407B-A915-BEFEC2BB7AD5
P2860
Inflammation as a causative factor in the aetiology of Parkinson's disease
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inflammation as a causative factor in the aetiology of Parkinson's disease
@ast
Inflammation as a causative factor in the aetiology of Parkinson's disease
@en
type
label
Inflammation as a causative factor in the aetiology of Parkinson's disease
@ast
Inflammation as a causative factor in the aetiology of Parkinson's disease
@en
prefLabel
Inflammation as a causative factor in the aetiology of Parkinson's disease
@ast
Inflammation as a causative factor in the aetiology of Parkinson's disease
@en
P2860
P356
P1476
Inflammation as a causative factor in the aetiology of Parkinson's disease
@en
P2093
P S Whitton
P2860
P304
P356
10.1038/SJ.BJP.0707167
P407
P577
2007-03-05T00:00:00Z